Search

Your search keyword '"Vidili, Gianpaolo"' showing total 246 results

Search Constraints

Start Over You searched for: Author "Vidili, Gianpaolo" Remove constraint Author: "Vidili, Gianpaolo"
246 results on '"Vidili, Gianpaolo"'

Search Results

1. Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease

2. ASO Visual Abstract: Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease

5. Rate and predictors of thromboprophylaxis in internal medicine wards: Results from the AURELIO study

6. Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care

7. Hypoalbuminemia and Risk of Portal Vein Thrombosis in Cirrhosis

10. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

11. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

12. Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications

13. Microplastics and nanoplastics in cardiovascular disease--a narrative review with worrying links.

14. Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice

15. Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.

16. Clinical history of cancer‐associated splanchnic vein thrombosis

17. Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis

18. Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice

19. A functional mammalian target of rapamycin complex 1 signaling is indispensable for c‐Myc‐driven hepatocarcinogenesis

20. Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells

21. Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma.

22. Comparison of 2D Shear Wave Elastography and Transient Elastography in Non-Invasive Evaluation of Liver Fibrosis in Hepatitis C Virus-Related Chronic Liver Disease.

23. Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27 KIP1 Regulation.

26. Red Cell Distribution Width as a Predictor of Survival in Patients with Hepatocellular Carcinoma.

30. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

31. Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.

32. Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma

33. Infectious Pneumonia and Lung Ultrasound: A Review

34. Gastrointestinal Ultrasound in Emergency Setting

36. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

37. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosis

38. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis

39. Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

40. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

41. Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment

42. Surveillance for hepatocellular carcinoma with a 3-months interval in 'extremely high-risk' patients does not further improve survival

43. Cholangiocarcinoma landscape in Europe:Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

44. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

46. Asymptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications

49. Monofocal hepatocellular carcinoma: How much does size matter?

50. Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment

Catalog

Books, media, physical & digital resources